Ovarian hyperstimulation syndrome

Common Name(s)

Ovarian hyperstimulation syndrome

Ovarian hyperstimulation syndrome (OHSS) is a disorder that usually is caused by taking hormonalmedications to stimulate the development of eggs in the ovaries. In OHSS, the ovaries become swollen and painful. Symptoms usually present within 10 days after taking the medications, though the severity of symptoms varies and may worsen or improve over time. Moderate symptoms include nausea, vomiting, diarrhea, abdominal bloating, mild abdominal pain, or tenderness in the ovary areas. Severe symptoms include dark urine, decreased urinary frequency, shortness of breath, severe abdominal pain, rapid weight gain, tight or enlarged abdomen, or dizziness.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Ovarian hyperstimulation syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Ovarian hyperstimulation syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Ovarian hyperstimulation syndrome" returned 110 free, full-text research articles on human participants. First 3 results:

Sequential E2 levels not ovarian maximal diameter estimates were correlated with outcome of cetrotide therapy for management of women at high-risk of ovarian hyperstimulation syndrome: a randomized controlled study.
 

Author(s): Khalid M Salama, Hesham M Abo Ragab, Mohammed F El Sherbiny, Ali A Morsi, Ibrahim I Souidan

Journal:

 

Ovarian hyperstimulation syndrome (OHSS) is an important condition with considerable morbidity and a small risk of mortality and most commonly results as an iatrogenic condition following follicular stimulation of the ovaries. We aimed to evaluate safety and efficacy of 3-day cetrotide ...

Last Updated: 31 Dec 1969

Go To URL
A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial.
 

Author(s): Ali Abbara, Sophie Clarke, Rumana Islam, Julia K Prague, Alexander N Comninos, Shakunthala Narayanaswamy, Deborah Papadopoulou, Rachel Roberts, Chioma Izzi-Engbeaya, Risheka Ratnasabapathy, Alexander Nesbitt, Sunitha Vimalesvaran, Rehan Salim, Stuart A Lavery, Stephen R Bloom, Les Huson, Geoffrey H Trew, Waljit S Dhillo

Journal: Hum. Reprod.. 2017 09;32(9):1915-1924.

 

Can increasing the duration of LH-exposure with a second dose of kisspeptin-54 improve oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS)?

Last Updated: 31 Dec 1969

Go To URL
A proteomic analysis identifies candidate early biomarkers to predict ovarian hyperstimulation syndrome in polycystic ovarian syndrome patients.
 

Author(s): Lan Wu, Yazhou Sun, Jun Wan, Ting Luan, Qing Cheng, Yong Tan

Journal: Mol Med Rep. 2017 Jul;16(1):272-280.

 

Ovarian hyperstimulation syndrome (OHSS) is a potentially life‑threatening, iatrogenic complication that occurs during assisted reproduction. Polycystic ovarian syndrome (PCOS) significantly increases the risk of OHSS during controlled ovarian stimulation. Therefore, a more effective ...

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Ovarian hyperstimulation syndrome" returned 14 free, full-text review articles on human participants. First 3 results:

Pharmacologic Interventions in Preventing Ovarian Hyperstimulation Syndrome: A Systematic Review and Network Meta-Analysis.
 

Author(s): Jun-Liang Guo, Duo-Duo Zhang, Yue Zhao, Dan Zhang, Xi-Meng Zhang, Can-Quan Zhou, Shu-Zhong Yao

Journal:

 

Ovarian hyperstimulation syndrome (OHSS) is a severe iatrogenic complication of controlled ovarian stimulation. Randomised controlled trials (RCTs) have proven several pharmacologic interventions to be effective in OHSS prevention, but these trials have seldom compared multiple drugs. ...

Last Updated: 31 Dec 1969

Go To URL
Severe ovarian hyperstimulation syndrome complicated by Stenotrophomonas maltophilia peritonitis: a case report and literature review.
 

Author(s): Abdul Rehman, Noor Ul-Ain Baloch, Muhammad Awais

Journal: Intern. Med.. 2015 ;54(9):1149-52.

 

Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic disorder resulting from ovulation induction. Although the occurrence of this disorder is rare, it can be potentially life-threatening in its most severe forms. We herein present the case of a young nulliparous woman who presented ...

Last Updated: 31 Dec 1969

Go To URL
Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention.
 

Author(s): C O Nastri, D M Teixeira, R M Moroni, V M S Leitão, W P Martins

Journal: Ultrasound Obstet Gynecol. 2015 Apr;45(4):377-93.

 

To identify, appraise and summarize the current evidence regarding the pathophysiology, staging, prediction and prevention of ovarian hyperstimulation syndrome (OHSS).

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

The Influence of Timing of Cabergoline Initiation on Prevention of OHSS
 

Status: Recruiting

Condition Summary: Ovarian Hyperstimulation Syndrome

 

Last Updated: 8 Apr 2018

Go to URL
Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response
 

Status: Recruiting

Condition Summary: Ovarian Hyperstimulation Syndrome; Hypercoagulability

 

Last Updated: 16 Feb 2018

Go to URL
Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET
 

Status: Not yet recruiting

Condition Summary: Ovarian Hyperstimulation Syndrome

 

Last Updated: 28 Feb 2017

Go to URL